In this study, researchers demonstrated that the use of metformin within the first four days of COVID-19 symptoms reduced healthcare utilization and the incidence of long COVID. The researchers write: "In conclusion, early outpatient COVID-19 treatment with metformin decreased the subsequent risk of long COVID by 41.3% during 10-month follow-up. This finding is consistent with the 42.3% reduction in healthcare utilization for severe COVID-19 with metformin in the first 14 days of the trial." Let's discuss.
DrBeen: Medical Education Onlinehttps://www.drbeen.com/
FLCCC | Front Line COVID-19 Critical Care Alliancehttps://covid19criticalcare.com/
URL list from Thursday, Oct. 5, 2023
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial - The Lancet Infectious Diseaseshttps://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00299-2/fulltext#%20
Disclaimer:This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.